Douglas E. Jones Net Worth

The estimated Net Worth of Douglas Edward Jones is at least $1.19 Million dollars as of 25 April 2024. Mr Jones owns over 845 units of Neogen stock worth over $716,384 and over the last 3 years he sold NEOG stock worth over $0. In addition, he makes $474,620 as VP & Chief Commercial Officer at Neogen.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Jones NEOG stock SEC Form 4 insiders trading

Mr has made over 6 trades of the Neogen stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 845 units of NEOG stock worth $10,106 on 25 April 2024.

The largest trade he's ever made was buying 10,000 units of Neogen stock on 17 April 2024 worth over $123,600. On average, Mr trades about 2,645 units every 68 days since 2021. As of 25 April 2024 he still owns at least 46,976 units of Neogen stock.

You can see the complete history of Mr Jones stock trades at the bottom of the page.

Mr. Douglas E. Jones biography

Douglas E. Jones is the VP & Chief Commercial Officer at Neogen.

What is the salary of Mr Jones?

As the VP & Chief Commercial Officer of Neogen, the total compensation of Mr Jones at Neogen is $474,620. There are 5 executives at Neogen getting paid more, with John Adent having the highest compensation of $2,123,450.

How old is Mr Jones?

Mr Jones is 51, he's been the VP & Chief Commercial Officer of Neogen since . There are 11 older and 3 younger executives at Neogen. The oldest executive at Neogen Corp. is G. Bruce Papesh, 73, who is the Independent Director.

What's Mr Jones's mailing address?

Douglas's mailing address filed with the SEC is Neogen, 620, Lesher Place, Oak Park, Lansing, Ingham County, Michigan, 48912, United States.

Insiders trading at Neogen

Over the last 24 years, insiders at Neogen have traded over $135,917,555 worth of Neogen stock and bought 195,554 units worth $4,379,833 . The most active insiders traders include James L Herbert, Jeffrey D Capello, and Lon M Bohannon. On average, Neogen executives and independent directors trade stock every 11 days with the average trade being worth of $140,346. The most recent stock trade was executed by Ronald D Green on 29 August 2024, trading 4,446 units of NEOG stock currently worth $68,780.

What does Neogen do?

neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.

Complete history of Mr Jones stock trades at Neogen

Neogen executives and stock owners

Neogen executives and other stock owners filed with the SEC include:

• John Adent,
  President, Chief Executive Officer, Director
• Steven Quinlan,
  Chief Financial Officer, Vice President, Secretary
• John Edward Adent,
  Pres, CEO & Director
• Jason Lilly,
  Vice President - International Business
• Jerome Hagedorn,
  Vice President - Food Safety operations
• Douglas E. Jones,
  VP & Chief Commercial Officer
• Steven J. Quinlan,
  VP & CFO
• James Borel,
  Lead Independent Chairman of the Board
• James Tobin,
  Independent Director
• Ronald Green,
  Independent Director
• William Boehm,
  Independent Director
• Darci Vetter,
  Independent Director
• G. Bruce Papesh,
  Independent Director
• Doug Jones,
  Chief Commercial Officer
• Amy M. Rocklin Ph.D.,
  VP, Gen. Counsel & Corp. Sec.
• Julie A. Mann,
  VP & Chief HR Officer
• Rod Poland,
  Director of Corp. Communications
• Amy Rocklin Ph.D.,
  VP & Gen. Counsel
• Sarah Demey,
  Admin. Mang.
• Bruce Papesh,
  Director
• A Charles Fischer,
  Director
• Richard E Jr Calk,
  President & COO
• Richard T Crowder,
  Director
• Jack C Parnell,
  Director
• Clayton K Yeutter,
  Director
• Thomas H Reed,
  Director
• Terri A Morrical,
  
• David H. Naemura,
  Chief Financial Officer
• Edward Bradley,
  V.P. Sales and Marketing
• Aashima Gupta,
  Director
• Jeffrey D Capello,
  Director
• Rex L Hamilton,
  Vice President
• Herbert D Doan,
  Director
• Gordon E Guyer,
  Director
• James L Herbert,
  Director
• Joseph M Madden,
  V.P. Scientific Affairs
• Richard R Current,
  Vice President & CFO
• Anthony E Maltese,
  VP Business Development
• Kenneth V Kodilla,
  Vice President
• Lon M Bohannon,
  COO
• Mark A Mozola,
  Vice President of R&D
• Leonard E Heller,
  Director
• Robert M Book,
  Director
• Stephen K. Snyder,
  Former Pres. and COO
• Paul S Satoh,
  V.P Research and Development
• Rafael A Rodriguez,
  Director
• Catherine E Woteki,
  Director
• Amy M Rocklin,
  Chief Legal Officer
• John Patrick Moylan,
  Chief Accounting Officer